# Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia

> **NCT00005603** · PHASE3 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 276 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** asparaginase
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** dexamethasone
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** prednisone
- **DRUG:** thioguanine
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00005603
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2005-09
- **Final completion:** —
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2014-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005603, "Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*